Perioperative chemotherapy for muscle-invasive bladder cancer: the importance of multidisciplinary management for evidence-based practice and transformative research

por Koshkin, Vadim S., Grivas, Petros
Publicado 2018

Improving Outcomes for Patients With Advanced Urothelial Carcinoma

por Grivas, Petros, Hammond, Jeannette
Publicado 2020

Emerging biomarkers in urothelial carcinoma: Challenges and opportunities

por Andreatos, Nikolaos, Iyer, Gopa, Grivas, Petros
Publicado 2020

Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review

por Koshkin, Vadim S., Osbourne, Appledene S., Grivas, Petros
Publicado 2021

The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape

por Koshkin, Vadim S., Basu, Arnab, Grivas, Petros
Publicado 2019

Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy

por Huan, Jianya, Grivas, Petros, Birch, Jasmine, Hansel, Donna E.
Publicado 2022

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook

por Gopalakrishnan, Dharmesh, Koshkin, Vadim S, Ornstein, Moshe C, Papatsoris, Athanasios, Grivas, Petros
Publicado 2018

Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer

por Zhu, Alec, Garcia, Jorge Alberto, Faltas, Bishoy, Grivas, Petros, Barata, Pedro, Shoag, Jonathan E.
Publicado 2023

Cancer and COVID-19 – Authors' reply

por Kuderer, Nicole M, Wulff-Burchfield, Elizabeth, Rubinstein, Samuel M, Grivas, Petros, Warner, Jeremy L
Publicado 2020

Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors

por Michailidou, Despina, Khaki, Ali Raza, Morelli, Maria Pia, Diamantopoulos, Leonidas, Singh, Namrata, Grivas, Petros
Publicado 2021

Expression of ERα, ERβ and Co-Regulator PELP1/MNAR in Colorectal Cancer: Prognostic Significance and Clinicopathologic Correlations

por Grivas, Petros D., Tzelepi, Vassiliki, Sotiropoulou-Bonikou, Georgia, Kefalopoulou, Zinovia, Papavassiliou, Athanasios G., Kalofonos, Haralabos
Publicado 2009

Use of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision‐Making Between Patients With Cancer and Clinicians

por Singh, Namrata, Grivas, Petros, Makris, Una E., Suarez‐Almazor, Maria E., O'Hare, Ann M., Barton, Jennifer L.
Publicado 2023

Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer

por Zargar, Homayoun, Almassi, Nima, Kovac, Evan, Ercole, Cesar, Remer, Erick, Rini, Brian, Stephenson, Andrew, Garcia, Jorge A., Grivas, Petros
Publicado 2017

Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy

por Haanen, John, Ernstoff, Marc, Wang, Yinghong, Menzies, Alexander, Puzanov, Igor, Grivas, Petros, Larkin, James, Peters, Solange, Thompson, John, Obeid, Michel
Publicado 2020

ATM/RB1 mutations predict shorter overall survival in urothelial cancer

por Yin, Ming, Grivas, Petros, Emamekhoo, Hamid, Mendiratta, Prateek, Ali, Siraj, Hsu, JoAnn, Vasekar, Monali, Drabick, Joseph J., Pal, Sumanta, Joshi, Monika
Publicado 2018

Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease

por Alexander, Swetha, Swami, Umang, Kaur, Aneet, Gao, Yubo, Fatima, Munazza, Ginn, Meredith M., Stein, Jill E., Grivas, Petros, Zakharia, Yousef, Singh, Namrata
Publicado 2021

Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer

por Joshi, Monika, Grivas, Petros, Mortazavi, Amir, Monk, Paul, Clinton, Steven K., Sue‐Ann Woo, Michele, Holder, Sheldon L., Drabick, Joseph J., Yin, Ming
Publicado 2020

Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors

por Vasavada, Shaleen, Panneerselvam, Kavea, Amin, Rajan, Varatharajalu, Krishnavathana, Okhuysen, Pablo C., Oliva, Isabella C. Glitza, Wang, Jianbo, Grivas, Petros, Thomas, Anusha S., Wang, Yinghong
Publicado 2022

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis

por Ghali, Fady, Zhao, Yibai, Patel, Devin, Jewell, Teresa, Yu, Evan Y., Grivas, Petros, Montgomery, R. Bruce, Gore, John L., Etzioni, Ruth B., Wright, Jonathan L.
Publicado 2022

Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry

por Peak, Taylor, Spiess, Philippe E, Li, Roger, Grivas, Petros, Necchi, Andrea, Pavlick, Dean, Huang, Richard S P, Lin, Douglas, Danziger, Natalie, Jacob, Joseph M, Bratslavsky, Gennady, Ross, Jeffrey S
Publicado 2023